Compare MANOJ SURGIC with GKB OPHTHALMICS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAAJ MEDISAFE vs GKB OPHTHALMICS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAAJ MEDISAFE GKB OPHTHALMICS RAAJ MEDISAFE/
GKB OPHTHALMICS
 
P/E (TTM) x 14.3 40.8 35.1% View Chart
P/BV x 40.7 0.7 5,437.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAAJ MEDISAFE   GKB OPHTHALMICS
EQUITY SHARE DATA
    RAAJ MEDISAFE
Mar-21
GKB OPHTHALMICS
Mar-21
RAAJ MEDISAFE/
GKB OPHTHALMICS
5-Yr Chart
Click to enlarge
High Rs1488 15.7%   
Low Rs937 24.3%   
Sales per share (Unadj.) Rs29.1112.9 25.8%  
Earnings per share (Unadj.) Rs2.1-2.7 -77.3%  
Cash flow per share (Unadj.) Rs2.83.5 78.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs1.0124.3 0.8%  
Shares outstanding (eoy) m10.945.04 217.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.40.6 71.0%   
Avg P/E ratio x5.4-22.9 -23.7%  
P/CF ratio (eoy) x4.117.7 23.4%  
Price / Book Value ratio x11.60.5 2,318.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m125314 39.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2479 31.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m318569 55.9%  
Other income Rs m024 0.9%   
Total revenues Rs m318593 53.7%   
Gross profit Rs m4112 338.4%  
Depreciation Rs m731 22.6%   
Interest Rs m720 36.6%   
Profit before tax Rs m26-16 -168.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3-2 -177.2%   
Profit after tax Rs m23-14 -167.7%  
Gross profit margin %12.72.1 605.0%  
Effective tax rate %12.211.6 105.0%   
Net profit margin %7.2-2.4 -299.9%  
BALANCE SHEET DATA
Current assets Rs m73740 9.9%   
Current liabilities Rs m65381 17.1%   
Net working cap to sales %2.563.1 4.0%  
Current ratio x1.11.9 57.8%  
Inventory Days Days552 9.4%  
Debtors Days Days56,265124,979,830 0.0%  
Net fixed assets Rs m93328 28.3%   
Share capital Rs m10950 216.3%   
"Free" reserves Rs m-98576 -17.1%   
Net worth Rs m11627 1.7%   
Long term debt Rs m8510 850.7%   
Total assets Rs m1661,068 15.6%  
Interest coverage x4.50.2 1,910.5%   
Debt to equity ratio x7.90 49,718.3%  
Sales to assets ratio x1.90.5 359.5%   
Return on assets %18.30.6 2,958.7%  
Return on equity %214.5-2.2 -9,800.9%  
Return on capital %35.10.8 4,642.3%  
Exports to sales %012.0 0.0%   
Imports to sales %012.0 0.0%   
Exports (fob) Rs mNA68 0.0%   
Imports (cif) Rs mNA68 0.0%   
Fx inflow Rs m068 0.0%   
Fx outflow Rs m068 0.0%   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m22-37 -60.9%  
From Investments Rs m-28-63 44.4%  
From Financial Activity Rs m528 18.5%  
Net Cashflow Rs m0-72 0.5%  

Share Holding

Indian Promoters % 73.5 59.7 123.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 0.0 2.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 40.3 65.9%  
Shareholders   8,664 1,434 604.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAAJ MEDISAFE With:   POLY MEDICURE    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

JLR, Corus, Tetley - Was Ratan Tata's Go Global Strategy Right Afterall? (Views On News)

Jan 20, 2022

Ratan Tata took the lead in global acquisitions and changed the mindset of India's business leaders. Was he successful after all?

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

Omicron: Sectors to Buy and Avoid in 2022 (Views On News)

Jan 11, 2022

We take a look at how stocks of 6 major sectors were impacted, the last time lockdowns were imposed and what we can learn from it.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Top 5 Bluechip Growth Stocks to Add to Your Watchlist (Views On News)

Jan 10, 2022

In a volatile market, these 'bluest of the bluechips' can bring stability to your portfolio.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAAJ MEDISAFE SHARE PRICE


Jan 20, 2022 (Close)

TRACK RAAJ MEDISAFE

  • Track your investment in RAAJ MEDISAFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAAJ MEDISAFE 5-YR ANALYSIS

COMPARE RAAJ MEDISAFE WITH

MARKET STATS